Altimmune, Inc. (ALT) CEO Vipin Garg on Q4 2021 Results - Earnings Call Transcript

Start Time: 08:30 January 1, 0000 9:16 AM ET

Altimmune, Inc. (NASDAQ:ALT)
Q4 2021 Earnings Conference Call
March 15, 2022, 08:30 AM ET

Company Participants

Vipin Garg - President and CEO
Richard Eisenstadt - CFO
Scot Roberts - Chief Scientific Officer
Scott Harris - Chief Medical Officer

Conference Call Participants

Seamus Fernandez - Guggenheim
Yasmeen Rahimi - Piper Sandler
Roger Song - Jefferies
Jon Wolleben - JMP Securities
Mayank Mamtani - B. Riley Securities
Patrick Trucchio - H.C. Wainwright

Operator

Good day, ladies and gentlemen, and welcome to the Altimmune, Inc. Full Year and Q4 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions]. As a reminder, this call is being recorded.

I would now like to introduce your host for today's conference, Rich Eisenstadt, Chief Financial Officer at Altimmune. Rich, you may begin.

Richard Eisenstadt

Thank you, Jonathan, and good morning, everyone. Thank you for participating in Altimmune's full year and fourth quarter 2021 earnings conference call. Members of the Altimmune team joining me on the call today are Vipin Garg, our Chief Executive Officer; Scot Roberts, our Chief Scientific Officer; and Scott Harris, our Chief Medical Officer. Following the prepared remarks, we will hold a question-and-answer session. A press release with our full year and fourth quarter 2021 financial results was issued this morning and can be found on the Investor Relations section of the company's Web site.

Before we begin, I would like to remind everyone that remarks about future expectations, plans, and prospects constitute forward-looking statements for purposes of Safe Harbor provisions under the Private Securities Litigation Reform Act of 1995. Altimmune cautions that these forward-looking statements are subject to risks and uncertainties that could cause actual results to differ